Literature DB >> 16920238

Tumor microenvironment and drug resistance in hematologic malignancies.

Zhi-Wei Li1, William S Dalton.   

Abstract

Increasing evidence supports the role of the tumor microenvironment in conferring drug resistance as a major cause of relapse and incurability of cancers. The tumor microenvironment consists of normal stromal cells, extracellular matrix, and soluble factors such as cytokines and growth factors. Tumor-tumor cell interaction, tumor-stromal cell interaction, as well as tumor-ECM interaction, all contribute to direct cell contact mediated drug resistance. In addition, soluble factors produced in the tumor microenvironment provide further signals for tumor cell growth and survival. Environment mediated-drug resistance (EM-DR) could be considered as the totality of cell adhesion mediated drug resistance (CAM-DR) and soluble factor mediated drug resistance (SM-DR) produced by the tumor-host interaction. This review focuses on the EM-DR model system and signaling pathways involved in cell survival of hematological malignancies.

Entities:  

Mesh:

Year:  2006        PMID: 16920238     DOI: 10.1016/j.blre.2005.08.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  48 in total

Review 1.  Cutaneous T-cell lymphomas: a review of new discoveries and treatments.

Authors:  Tara Bloom; Timothy M Kuzel; Christiane Querfeld; Joan Guitart; Steven T Rosen
Journal:  Curr Treat Options Oncol       Date:  2012-03

2.  Spheroid-based drug screen: considerations and practical approach.

Authors:  Juergen Friedrich; Claudia Seidel; Reinhard Ebner; Leoni A Kunz-Schughart
Journal:  Nat Protoc       Date:  2009-02-12       Impact factor: 13.491

Review 3.  Evolutionary scalpels for dissecting tumor ecosystems.

Authors:  Daniel I S Rosenbloom; Pablo G Camara; Tim Chu; Raul Rabadan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-12-05       Impact factor: 10.680

4.  Transcriptomic silencing as a potential mechanism of treatment resistance.

Authors:  Jacob J Adashek; Shumei Kato; Rahul Parulkar; Christopher W Szeto; J Zachary Sanborn; Charles J Vaske; Stephen C Benz; Sandeep K Reddy; Razelle Kurzrock
Journal:  JCI Insight       Date:  2020-06-04

5.  Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia.

Authors:  Xin Long; Yang Yu; Laszlo Perlaky; Tsz-Kwong Man; Michele S Redell
Journal:  Br J Haematol       Date:  2015-05-14       Impact factor: 6.998

6.  MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.

Authors:  Edward Allan R Sison; Rachel E Rau; Emily McIntyre; Li Li; Donald Small; Patrick Brown
Journal:  Br J Haematol       Date:  2013-01-07       Impact factor: 6.998

7.  Definition of a multiple myeloma progenitor population in mice driven by enforced expression of XBP1s.

Authors:  Joshua Kellner; Caroline Wallace; Bei Liu; Zihai Li
Journal:  JCI Insight       Date:  2019-04-04

8.  Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Authors:  George S Laszlo; Todd A Alonzo; Chelsea J Gudgeon; Kimberly H Harrington; Robert B Gerbing; Yi-Cheng Wang; Rhonda E Ries; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Roland B Walter
Journal:  Clin Cancer Res       Date:  2015-03-30       Impact factor: 12.531

9.  Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy.

Authors:  Marco Ragusa; Giuseppe Avola; Rosario Angelica; Davide Barbagallo; Maria Rosa Guglielmino; Laura R Duro; Alessandra Majorana; Luisa Statello; Loredana Salito; Carla Consoli; Maria Grazia Camuglia; Cinzia Di Pietro; Giuseppe Milone; Michele Purrello
Journal:  BMC Cancer       Date:  2010-07-19       Impact factor: 4.430

10.  Caspase-8 association with the focal adhesion complex promotes tumor cell migration and metastasis.

Authors:  Simone Barbero; Ainhoa Mielgo; Vicente Torres; Tal Teitz; David J Shields; David Mikolon; Matthew Bogyo; Daniela Barilà; Jill M Lahti; David Schlaepfer; Dwayne G Stupack
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.